Codice:
E023052
ISSN:
0006-4971
Dati Generali
Pubblicazioni (258)
Bortezomib and plasma cell leukemia
AbstractEffect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
Contributo in Atti di convegnoEffect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
Contributo in Atti di convegnoTargeting LSCs: powering an old tool
ArticoloThe biology of CML blast crisis
ArticoloNo Results Found